Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release
DB Zorov, M Juhaszova, SJ Sollott - Physiological reviews, 2014 - journals.physiology.org
Byproducts of normal mitochondrial metabolism and homeostasis include the buildup of
potentially damaging levels of reactive oxygen species (ROS), Ca2+, etc., which must be …
potentially damaging levels of reactive oxygen species (ROS), Ca2+, etc., which must be …
The mitochondrial death pathway: a promising therapeutic target in diseases
• Introduction• Mitochondria and cell death• Mitochondrial outer membrane permeabilization
(MOMP): point of no return‐MOMP by BCL‐2 family proteins‐MOMP by permeability …
(MOMP): point of no return‐MOMP by BCL‐2 family proteins‐MOMP by permeability …
Minocycline inhibits poly (ADP-ribose) polymerase-1 at nanomolar concentrations
CC Alano, TM Kauppinen, AV Valls… - Proceedings of the …, 2006 - National Acad Sciences
Poly (ADP-ribose) polymerase-1 (PARP-1), when activated by DNA damage, promotes both
cell death and inflammation. Here we report that PARP-1 enzymatic activity is directly …
cell death and inflammation. Here we report that PARP-1 enzymatic activity is directly …
Involvement of the kynurenine pathway in the pathogenesis of Parkinson's disease
Parkinson's disease (PD) is a common neurodegenerative disorder characterized by loss of
dopaminergic neurons and localized neuroinflammation occurring in the midbrain several …
dopaminergic neurons and localized neuroinflammation occurring in the midbrain several …
The interplay between gut microbiota and Parkinson's disease: Implications on diagnosis and treatment
A Varesi, LIM Campagnoli, F Fahmideh… - International journal of …, 2022 - mdpi.com
The bidirectional interaction between the gut microbiota (GM) and the Central Nervous
System, the so-called gut microbiota brain axis (GMBA), deeply affects brain function and …
System, the so-called gut microbiota brain axis (GMBA), deeply affects brain function and …
What is behind the non-antibiotic properties of minocycline?
N Garrido-Mesa, A Zarzuelo, J Galvez - Pharmacological research, 2013 - Elsevier
Minocycline is a second-generation, semi-synthetic tetracycline that has been in use in
therapy for over 30 years for its antibiotic properties against both Gram-positive and Gram …
therapy for over 30 years for its antibiotic properties against both Gram-positive and Gram …
Cure of alzheimer's dementia requires addressing all of the affected brain cell types
J Fessel - Journal of Clinical Medicine, 2023 - mdpi.com
Multiple genetic, metabolic, and environmental abnormalities are known to contribute to the
pathogenesis of Alzheimer's dementia (AD). If all of those abnormalities were addressed it …
pathogenesis of Alzheimer's dementia (AD). If all of those abnormalities were addressed it …
A neurodegeneration gene, WDR45, links impaired ferritinophagy to iron accumulation
L Aring, EK Choi, H Kopera, T Lanigan… - Journal of …, 2022 - Wiley Online Library
Neurodegeneration with brain iron accumulation (NBIA) is a clinically and genetically
heterogeneous group of neurodegenerative diseases characterized by the abnormal …
heterogeneous group of neurodegenerative diseases characterized by the abnormal …
Neuroprotectant minocycline depresses glutamatergic neurotransmission and Ca2+ signalling in hippocampal neurons
JC González, J Egea… - European Journal of …, 2007 - Wiley Online Library
The mechanism of the neuroprotective action of the tetracycline antibiotic minocycline
against various neuron insults is controversial. In an attempt to clarify this mechanism, we …
against various neuron insults is controversial. In an attempt to clarify this mechanism, we …
Mitochondria and calcium flux as targets of neuroprotection caused by minocycline in cerebellar granule cells
EM Garcia-Martinez, S Sanz-Blasco… - Biochemical …, 2010 - Elsevier
Minocycline, an antibiotic of the tetracycline family, has attracted considerable interest for its
theoretical therapeutic applications in neurodegenerative diseases. However, the …
theoretical therapeutic applications in neurodegenerative diseases. However, the …